Aclaris Therapeutics, Inc. (ACRS) stock
Close on Nov 13, 2026Market cap $577.02MP/E –Yield –
Aclaris Therapeutics statistics
78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.46
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 58.18
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 17.4%
- 10.8%
- Shares Change (QoQ)
- 7.87%
- 0.50%
- Float
- 128M
- 49M
- Shares Held by Insiders
- 13.3%
- 11.7%
- Shares Held by Institutions
- 82.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 12M
- –
- Short Interest Change
- -23.0%
- -0.80%
- Short % of Float
- 9.06%
- 9.01%
- Short % of Shares Outstanding
- 7.86%
- 6.30%
- Days to Cover
- 4.02
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $6.60
- –
- 52-Week Low
- $2.25
- –
- 20-Day Moving Average
- $3.88
- –
- 50-Day Moving Average
- $4.43
- –
- 200-Day Moving Average
- $4.54
- –
- Average True Range (14)
- $0.30
- –
- Price Change (1 Week)
- 0.51%
- -1.15%
- Price Change (1 Month)
- 12.3%
- -4.87%
- Price Change (3 Months)
- -33.8%
- -21.0%
- Price Change (6 Months)
- -13.3%
- -20.6%
- Price Change (YTD)
- 30.2%
- -23.6%
- Price Change (1 Year)
- 62.7%
- -22.4%
- Price Change (3 Years)
- 476.4%
- -29.5%
- Price Change (5 Years)
- -73.7%
- -77.9%
- Price Change (10 Years)
- -82.6%
- -65.4%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.44
- 0.70
- Relative Strength Index (14)
- 46.9
- 43.4
- Volatility (1 Year)
- 98.2%
- 80.1%
- Beta (5 Years)
- 1.13
- 1.07
MarginsIndustry
- EBITDA Margin
- -1407.5%
- -27.7%
- FCF Margin
- -1176.6%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -55.5%
- -49.9%
- Return on Assets (ROA)
- -40.7%
- -40.6%
- Return on Capital Employed (ROCE)
- -47.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 5.09
- 3.30
- Quick Ratio
- 8.45
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- -59.3%
- 6.82%
- Revenue Growth (3Y CAGR)
- -35.9%
- 2.25%
- Revenue Growth (5Y CAGR)
- 3.84%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.03
- 0.40
- Revenue Per Employee
- $87.68K
- $429.29K
- Profits Per Employee
- -$1.09M
- -$689.41K
- Employee Count
- 73
- 74
- WACC
- 10.8%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $204.60M
- $17.76M
- Net Cash Per Share
- $1.39
- $0.80
- Equity (Book Value)
- $166.80M
- $53.89M
- Book Value Per Share
- $1.13
- $1.50
- Tangible Book Value
- $166.80M
- $27.13M
- Working Capital
- $99.01M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$108.00K
- -$1.00M
- FCF Per Share
- -$0.51
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -13.8%
- -21.8%
- FCF Yield
- -13.1%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- -0.44
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ACRS | S&P 500 | Difference | ACRS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +13.0% | -3.0% | +16.0 pts | ||
| 3 months | -33.1% | -2.8% | −30.3 pts | ||
| Year to date | +30.2% | +11.5% | +18.7 pts | ||
| 1 year | +69.0% | +13.5% | +55.5 pts | ||
| 3 years | +507.8% | +77.7% | +430.1 pts | +82.5% | +21.1% |
| 5 years | -73.7% | +72.6% | −146.3 pts | -23.4% | +11.5% |
| 10 years | -82.7% | +308.2% | −390.9 pts | -16.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
12M ACRS shares were sold short on Oct 30, 2026, down 23.0% from the previous report, or 9.06% of the shares available to trade. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 51.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 11,572,867 | -23.0% | 2,876,959 | 4.0 |
| Oct 15, 2026 | 15,027,284 | -17.4% | 5,100,513 | 3.0 |
| Sep 30, 2026 | 18,191,280 | +13.2% | 2,808,944 | 6.5 |
| Sep 15, 2026 | 16,075,295 | +5.9% | 2,521,511 | 6.4 |
| Aug 31, 2026 | 15,180,778 | +3.2% | 1,751,825 | 8.7 |
| Aug 14, 2026 | 14,710,712 | +6.8% | 2,097,926 | 7.0 |
| Jul 31, 2026 | 13,774,975 | +3.1% | 1,591,424 | 8.7 |
| Jul 15, 2026 | 13,357,058 | +17.1% | 1,931,350 | 6.9 |
| Jun 30, 2026 | 11,404,860 | +28.2% | 2,671,298 | 4.3 |
| Jun 15, 2026 | 8,899,127 | +10.2% | 1,312,804 | 6.8 |
| May 29, 2026 | 8,075,151 | +9.9% | 915,723 | 8.8 |
| May 15, 2026 | 7,345,278 | -6.9% | 1,307,000 | 5.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?